A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor (KCSG LU17-21)H. A. Jung,M. Kim,J. Kim,Y. H. Choi,J. Cho,J. H. Park,K. U. Park, S. Park,J. Sun, S. Lee,J. S. Ahn,K. Park,M. AhnJOURNAL OF THORACIC ONCOLOGY（2021）引用 2|浏览6暂无评分关键词Palbociclib, Cyclin D1, Thymic Epithelial TumorsAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
